Astrazeneca Allies with Taiwan in Drug Repurposing Project
TAIPEI, Taiwan – Astrazeneca plc and Taiwan’s National Research Program for Biopharmaceuticals (NRPB) are collaborating to repurpose a basket of clinical-stage drug candidates provided by the London-based big pharma for possible new therapies targeting Asian-prevalent diseases, using an open innovation model of development.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST